| Literature DB >> 32363255 |
Bui Thi Phuong Thuy1, Tran Thi Ai My2, Nguyen Thi Thanh Hai2, Le Trung Hieu2, Tran Thai Hoa2, Huynh Thi Phuong Loan2, Nguyen Thanh Triet3, Tran Thi Van Anh4, Phan Tu Quy5, Pham Van Tat6, Nguyen Van Hue7, Duong Tuan Quang8, Nguyen Tien Trung9, Vo Thanh Tung10, Lam K Huynh11,12, Nguyen Thi Ai Nhung2.
Abstract
Eighteen active substances, including 17 organosulfur compounds found in garlic essential oil (T), were identified by GC-MS analysis. For the first time, using the molecular docking technique, we report the inhibitory effect of the considered compounds on the host receptor angiotensin-converting enzyme 2 (ACE2) protein in the human body that leads to a crucial foundation about coronavirus resistance of individual compounds on the main protease (PDB6LU7) protein of SARS-CoV-2. The results show that the 17 organosulfur compounds, accounting for 99.4% contents of the garlic essential oil, have strong interactions with the amino acids of the ACE2 protein and the main protease PDB6LU7 of SARS-CoV-2. The strongest anticoronavirus activity is expressed in allyl disulfide and allyl trisulfide, which account for the highest content in the garlic essential oil (51.3%). Interestingly, docking results indicate the synergistic interactions of the 17 substances, which exhibit good inhibition of the ACE2 and PDB6LU7 proteins. The results suggest that the garlic essential oil is a valuable natural antivirus source, which contributes to preventing the invasion of coronavirus into the human body.Entities:
Year: 2020 PMID: 32363255 PMCID: PMC7123907 DOI: 10.1021/acsomega.0c00772
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1Picture of garlic (A. sativum L.).
Scheme 1(A) Angiotensin-Converting Enzyme 2 (ACE2) in the Human Body and (B) PDB6LU7 Protein in SARS-CoV-2 Main Protease
Figure 2GC–MS chromatogram of garlic essential oil.
Identification of the Bioactive Compounds in Garlic Essential Oil
Docking Simulation Results with Docking Score Energy (DS) and Root-Mean-Square Deviation (RMSD) between Compounds in Garlic Essential Oil and the ACE2 Protein
| T5 =
T11 > T1 = T2 > T4 > T8 > T9 > T12 > T13 > T14
> T15 > T3 > T7 > T10
> T16 > T17 > T6 | ||||
|---|---|---|---|---|
| compound | symbol (compound-protein) | DS (kcal·mol–1) | RMSD (Å) | interaction with amino acid |
| allyl disulfide | –12.84 | 1.46 | Pro 565 (2.85 Å), Trp 566 (2.87 Å), Ala 396 (3.14 Å) | |
| allyl trisulfide | –12.76 | 1.47 | Gln 102 (2.89 Å; 3.11 Å), Asn 103 (3.45 Å) | |
| allyl ( | –9.07 | 0.66 | Glu 208 (3.06 Å), Gly 205 (3.70 Å) | |
| allyl methyl trisulfide | –12.50 | 1.56 | Asn 210 (3.13 Å; 3.05 Å), Lys 94 (3.22 Å) | |
| diallyl tetrasulfide | –14.06 | 1.23 | Gly 205 (3.43 Å), Asp 206 (2.95 Å), Lys 562 (2.92 Å), Ala 396 (3.82 Å) | |
| 1,2-dithiole | –7.89 | 3.09 | Asn 210 (3.29 Å) | |
| allyl ( | –9.04 | 1.58 | Gln 98 (4.14 Å), Glu 208 (3.24 Å) | |
| 2-vinyl-4 | –11.83 | 0.62 | Gln 98 (3.10 Å), Val 209 (3.56 Å), Asn 210 (3.93 Å) | |
| 3-vinyl-1,2-dithiacyclohex-4-ene | –10.57 | 1.19 | Trp 566 (2.78 Å), Pro 565 (3.95 Å), Glu 208 (3.12 Å) | |
| carvone | –8.58 | 1.53 | Lys 94 (2.13 Å), Gln 98 (1.72 Å) | |
| trisulfide, 2-propenyl propyl | –14.01 | 1.85 | Trp 566 (3.51 Å), Glu 208 (3.66 Å), (3.05 Å), Val 209 (3.25 Å), Gln 98 (3.52 Å) | |
| methyl allyl disulfide | –10.32 | 1.16 | Val 209 (2.31 Å), Gln 98 (3.45 Å), Lys 94 (3.15 Å) | |
| diacetonalcohol | –9.71 | 0.85 | Gln 101 (2.13 Å), Asn 210 (1.97 Å; 2.05 Å) | |
| trisulfide, (1 | –9.57 | 0.68 | Asn 210 (3.20 Å; 1.72 Å), Ser 563 (3.73 Å) | |
| allyl sulfide | –9.38 | 1.48 | Asn 210 (2.31 Å), Lys 94 (3.15 Å), Gln 98 (3.45 Å) | |
| 1-propenyl methyl disulfide | –8.06 | 0.88 | Asp 206 (2.81 Å), Trp 566 (3.46 Å) | |
| trisulfide, (1 | –8.06 | 2.35 | Glu 208 (3.29 Å), Gln 98 (3.64 Å) | |
Figure 3(A) Native human angiotensin-converting enzyme 2 (ACE2) crystal structure. Docking simulation of the interaction between compounds T5, T11, T1, T2, T4, and the ACE2 protein in the human body: (B) T5-ACE2, (C) T11-ACE2, (D) T1-ACE2, (E) T2-ACE2, and (F) T4-ACE2. The inhibitory effects of the compounds on the ACE2 protein are of the order: T5 ≈ T11 > T1 ≈ T2 > T4.
Docking Simulation Results with Docking Score Energy (DS) and Root-Mean-Square Deviation (RMSD) between the Title Compounds and PDB6LU7 Protein of SARS-CoV-2
| T2 =
T1 > T5 > T4 > T11 > T15 > T8 > T16 > T9 >
T12 > T13 > T3 > T6 > T7
> T10 > T14 > T17 | ||||
|---|---|---|---|---|
| compound | symbol (compound-protein) | DS (kcal·mol–1) | RMSD (Å) | interaction with amino acid |
| allyl disulfide | –15.32 | 1.35 | Gly 143 (2.59 Å), Asn 142 (2.92 Å), Leu 141 (2.94 Å), Cys 145 (2.98 Å), Ser 144 (3.15 Å), His 163 (2.95 Å) | |
| allyl trisulfide | –15.02 | 0.66 | Gly 143 (3.93 Å; 2.79 Å), Asn 142 (2.87 Å; 2.67 Å), Cys 145 (3.25 Å; 3.63 Å), Ser 144 (3.06 Å) | |
| allyl ( | –13.25 | 1.49 | Leu 141 (2.98 Å), Ser 144 (3.07 Å) | |
| allyl methyl trisulfide | –14.36 | 1.37 | Gly 143 (3.69 Å), Asn 142 (2.81 Å), Cys 145 (3.61 Å; 3.12 Å), Ser 144 (2.96 Å) | |
| diallyl tetrasulfide | –14.47 | 0.94 | Gly 143 (2.88 Å; 2.98 Å), Asn 142 (2.10 Å), Cys 145 (3.94 Å; 3.56 Å), Ser 144 (3.14 Å) | |
| 1,2-dithiole | –13.21 | 2.30 | Asn 142 (3.75 Å), Cys 145 (3.75 Å) | |
| allyl ( | –12.60 | 1.72 | Gly 143 (3.32 Å), Leu 141 (3.62 Å) | |
| 2-vinyl-4 | –14.04 | 4.35 | Gly 143 (2.73 Å), Asn 142 (3.82 Å), Cys 145 (3.11 Å), Ser 144 (3.02 Å) | |
| 3-vinyl-1,2-dithiacyclohex-4-ene | –13.83 | 1.05 | Glu 166 (2.86 Å), Met 165 (2.88 Å), Cis 145 (2.13 Å) | |
| carvone | –12.36 | 1.62 | His 163 (2.15 Å) | |
| trisulfide, 2-propenyl propyl | –14.36 | 1.37 | Gly 143 (2.62 Å; 2.81 Å), Asn 142 (2.85 Å), Cys 145 (3.15 Å; 3.50 Å), Ser 144 (2.87 Å), His 163 (2.97 Å) | |
| methyl allyl disulfide | –13.56 | 1.51 | Cys 145 (2.43 Å), Ser 144 (2.82 Å), His 163 (2.65 Å) | |
| diacetonalcohol | –13.26 | 1.41 | Cys 145 (2.93 Å), Ser 144 (2.26 Å) | |
| trisulfide, (1 | –12.00 | 2.12 | Leu 141 (3.32 Å), Ser 144 (2.39 Å) | |
| allyl sulfide | –14.24 | 1.20 | Gly 143 (2.75 Å), Asn 142 (2.75 Å), Leu 141 (3.56 Å), Cys 145 (3.47 Å), Ser 144 (3.32 Å) | |
| 1-propenyl methyl disulfide | –13.84 | 0.91 | Gly 143 (2.89 Å), Asn 142 (3.88 Å), Cys 145 (2.83 Å), Ser 144 (2.80 Å) | |
| trisulfide,
(1 | –11.68 | 3.60 | Leu 141 (3.38 Å) | |
Figure 4(A) Crystal structure of the virus main protease in the complex (PDB6LU7). Docking simulation of the interaction between compounds T1, T2, T4, T5, and T11, and the PDB6LU7 protein of SARS-CoV-2: (B) T1-SARS-CoV-2, (C) T2-SARS-CoV-2, (D) T4-SARS-CoV-2, (E) T5-SARS-CoV-2, and (F) T11-SARS-CoV-2. The inhibitory effects of the compounds on the PDB6LU7 protein of SARS-CoV-2 were of the order: T1 ≈ T2 > T5 > T4 > T11.
Figure 53D-docking results with simultaneous interaction of all 17 substances (17T = T1–T17) in the garlic essential oil with (A) ACE2 protein and (B) PDB6LU7 protein of SARS-CoV-2.